| Dr Julian Murphree Thomas, MD | |
|
3940 Montclair Rd, Suite 410, Birmingham, AL 35213-2427 | |
| (205) 879-7066 | |
| (205) 871-5066 |
| Full Name | Dr Julian Murphree Thomas |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 3940 Montclair Rd, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255320115 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0101X | Dermatology - Mohs-micrographic Surgery | 10357 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Julian Murphree Thomas, MD 3940 Montclair Rd, Suite 410, Birmingham, AL 35213-2427 Ph: (205) 879-7066 | Dr Julian Murphree Thomas, MD 3940 Montclair Rd, Suite 410, Birmingham, AL 35213-2427 Ph: (205) 879-7066 |
News Archive
Nuvilex, Inc. announced today it has entered into discussions to acquire the next generation live cell encapsulation technology that serves as the platform for multiple cancer therapies.
The Associated Press reports on this development - which it called a "new wrinkle" - that will move up by about six weeks the date by which consumers will need to have health insurance or face penalties. Also in the news, lots of talk - some of which came from President Barack Obama himself - about how the health law helps or hurts workers and how it impacts health care costs.
Medco Health Solutions, Inc. today reported record fourth-quarter 2011 GAAP diluted EPS of $1.08, an increase of 22.7 percent, which includes expenses associated with the pending merger with Express Scripts, Inc. of $43.6 million before provision for income taxes. When excluding these merger-related expenses, diluted EPS increased 29.5 percent over fourth-quarter 2010.
A new clinical study has found that erlotinib, a targeted antitumor agent, has promising potential to improve treatment for cervical cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the results indicate that larger trials are warranted to determine whether the drug should become part of standard therapy for women with the disease.
A national conference in South Africa was dominated this week by the continuing debate over HIV/AIDS drugs.
› Verified 2 days ago
Callie Roberts Hill, Dermatology Medicare: Medicare Enrolled Practice Location: 1927 1st Ave N, Birmingham, AL 35203 Phone: 205-933-0987 Fax: 205-930-1750 | |
Carly Elston, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 500 22nd St S, Birmingham, AL 35233 Phone: 205-934-9999 | |
Tiffany Mayo, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Daniel Bergman, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 Fax: 205-297-9411 | |
Carlton Phillips, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2100 16th Ave S, Birmingham, AL 35205 Phone: 205-933-0987 Fax: 205-930-1758 | |
Katherine Flanagan, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 813 Shades Creek Pkwy, Suite 205, Birmingham, AL 35209 Phone: 205-578-1799 Fax: 205-578-3158 | |
Vijay Balakrishnan, MD Dermatology Medicare: Medicare Enrolled Practice Location: 510 20th St S Ste 858, Birmingham, AL 35233 Phone: 205-934-5188 |